Intestinal Carcinoid Tumors

Malignant carcinoid tumors of the intestine. Susceptibility may be hereditary (autosomal dominant) or due to de novo mutations. Variations in the SDHD gene have been identified. OMIM: 114900

Also Known As:

Networked: 14 relevant articles (0 outcomes, 1 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Neoplasms (Cancer)
2.	Insulinoma
3.	Carcinoid Tumor (Carcinoid)
4.	Neuroendocrine Tumors (Neuroendocrine Tumor)
5.	Gastrinoma

Experts

1.	Jin, Long: 2 articles (03/2010 - 01/2007)
2.	Leontovich, Alexey A: 2 articles (03/2010 - 01/2007)
3.	Lloyd, Ricardo V: 2 articles (03/2010 - 01/2007)
4.	Stilling, Gail A: 2 articles (03/2010 - 01/2007)
5.	Zhang, Shuya: 2 articles (03/2010 - 01/2007)
6.	Almhanna, Khaldoun: 1 article (05/2013)
7.	Feldman, Max: 1 article (05/2013)
8.	Goldman, Jamie: 1 article (05/2013)
9.	Kvols, Larry: 1 article (05/2013)
10.	Strosberg, Jonathan: 1 article (05/2013)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Intestinal Carcinoid Tumors:

1.	DNA (Deoxyribonucleic Acid)IBA 08/01/1986 - "DNA distribution pattern in intestinal carcinoid tumors." 08/15/1985 - "Nuclear DNA in intestinal carcinoid tumors. " 03/01/1989 - "Paraffin-embedded archival tissue samples were used for nuclear deoxyribonucleic acid (DNA) content study by flow cytometry on 56 surgically resected, primary, small-intestinal carcinoid tumors. "
2.	ParaffinIBA 03/01/1989 - "Paraffin-embedded archival tissue samples were used for nuclear deoxyribonucleic acid (DNA) content study by flow cytometry on 56 surgically resected, primary, small-intestinal carcinoid tumors. "
3.	Biomarkers (Surrogate Marker)IBA 03/01/2010 - "These results provide information about novel marker miRNAs that may be used as biomarkers and/or therapeutic targets in intestinal carcinoid tumors." 12/01/1983 - "Serum markers for pancreatic islet cell and intestinal carcinoid tumors: a comparison of neuron-specific enolase, beta-human chorionic gonadotropin and pancreatic polypeptide."
4.	Octreotide (Sandostatin)FDA LinkGeneric 05/01/2013 - "Above-Label Doses of Octreotide-LAR in Patients With Metastatic Small Intestinal Carcinoid Tumors." 04/01/1996 - "[111IN-octreotide and 123I-MIBG scintigraphy in the diagnosis of small intestinal carcinoid tumors--results of a comparative investigation]."
5.	Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA 12/01/1983 - "Serum markers for pancreatic islet cell and intestinal carcinoid tumors: a comparison of neuron-specific enolase, beta-human chorionic gonadotropin and pancreatic polypeptide." 05/15/1983 - "The intestinal carcinoid tumors of 26 patients were stained for the presence of serotonin, gastrin, somatostatin, motilin, secretin, glucagon, pancreatic polypeptide, ACTH, and neurotensin. "
6.	MicroRNAs (MicroRNA)IBA 03/01/2010 - "These results provide information about novel marker miRNAs that may be used as biomarkers and/or therapeutic targets in intestinal carcinoid tumors."
7.	Gastrin-Releasing PeptideIBA 10/01/1984 - "The recent observation that gastrin-releasing peptide (GRP), a 27 amino acid peptide first isolated from porcine intestine, may be the mammalian analog of bombesin led us to look for this peptide in intestinal carcinoid tumors. "
8.	3-Iodobenzylguanidine (Iobenguane)IBA 06/01/1998 - "[Clinical relevance of I-123/I-131-MIBG scintigraphy in intestinal carcinoid tumors]."
9.	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 05/15/1983 - "The intestinal carcinoid tumors of 26 patients were stained for the presence of serotonin, gastrin, somatostatin, motilin, secretin, glucagon, pancreatic polypeptide, ACTH, and neurotensin. "
10.	Serotonin (5 Hydroxytryptamine)IBA 05/15/1983 - "The intestinal carcinoid tumors of 26 patients were stained for the presence of serotonin, gastrin, somatostatin, motilin, secretin, glucagon, pancreatic polypeptide, ACTH, and neurotensin. "